Building Strong Data Foundations And Smart Logistics For Scalable CGT Development

In this segment of Cell & Gene Live, Designing Early Manufacturing For Long-Term Success In CGT, Raymond Luke, Senior Director of MSAT at Verismo Therapeutics and Todd Luman, Executive Director of Process and Product Development at Allogene emphasize that early investment in analytics and structured data collection is essential to guide scale-up and regulatory success. Luke stresses capturing all available data, not just release specs, while fostering cross-functional collaboration between CMC and clinical teams to interpret patient-specific variables and improve product understanding. Luman advises emerging biotechs to prioritize standardized data architecture and proven visualization tools over custom-built systems, ensuring insights are scalable and reproducible.